SCHEMBL27273620

SCHEMBL27273620

CCc1c(C(=O)OC)cccc1C(F)(F)F

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CTSS P25774 4/20 0.45
LMNA P02545 2/20 0.42
GAA P10253 1/20 0.42
KCNK3 O14649 1/20 0.42
KCNK9 Q9NPC2 1/20 0.42
CFTR P13569 4/20 0.42
TSHR P16473 1/20 0.42
KDM4E B2RXH2 3/20 0.42
GLA P06280 1/20 0.42
PDK2 Q15119 1/20 0.42
CTSK P43235 1/20 0.41
F2R P25116 1/20 0.41
RBP4 P02753 1/20 0.41
ALDH1A1 P00352 2/20 0.41
HSD17B10 Q99714 1/20 0.41
NOTUM Q6P988 1/20 0.41
HPGD P15428 1/20 0.41
TDP1 Q9NUW8 1/20 0.41
KMT2A Q03164 1/20 0.41
TAS2R14 Q9NYV8 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30935916 0.88 LMNA (0.42) CTSSLMNAGAACFTRTSHR
SCHEMBL4630905 0.86 NOTUM (0.43) CTSSLMNAGAAKCNK3KCNK9
SCHEMBL30935926 0.86 CFTR (0.44) CTSSLMNAGAACFTRTSHR
SCHEMBL28052334 0.84 NOTUM (0.41) CTSSLMNAGAAKCNK3KCNK9
SCHEMBL22481057 0.83 LMNA (0.53) LMNAGAACFTRTSHRKDM4E
SCHEMBL10397075 0.82 TAS2R14 (0.50) CTSSLMNAGAACTSKF2R
SCHEMBL29286662 0.81 CD38 (0.46) CTSSLMNAGAACTSKF2R
SCHEMBL45490 0.80 LMNA (0.59) LMNAGAACFTRTSHRKDM4E
SCHEMBL28680548 0.80 ALDH1A1 (0.53) LMNAGAACFTRTSHRKDM4E
Hydrochloric Acid SCHEMBL4589099 0.79 CD38 (0.45) CTSSLMNAGAACTSKF2R

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024112692-A1 CASITAS B-LINEAGE LYMPHOMA PROTOONCOGENE B (CBL-B) DEGRADING COMPOUNDS AND ASSOCIATED METHODS OF USE ARVINAS OPERATIONS, INC. (US) 2024-05-30 WO disclosed
WO-2024112692-A1 CASITAS B-LINEAGE LYMPHOMA PROTOONCOGENE B (CBL-B) DEGRADING COMPOUNDS AND ASSOCIATED METHODS OF USE ARVINAS OPERATIONS, INC. (US) 2024-05-30 WO disclosed